The prevalence of chronic conditions has risen to unprecedented levels over the past twenty years, with nearly 1-in-3 young people estimated to now be living with pediatric onset conditions that significantly affect their lives, new research suggests.
Study shows CAR T-cell therapy’s risk of second primary malignancies comparable to other treatments
The frequency of second primary malignancies (SPMs) arising in cancer survivors following treatment with CAR T-cell therapy was statistically comparable to the frequency of SPMs
September 11, 2024